Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

2.

Non-invasive low frequency vibration as a potential emergency adjunctive treatment for heart attack and stroke. An in vitro flow model.

Yohannes FG, Hoffmann AK.

J Thromb Thrombolysis. 2008 Jun;25(3):251-8. Epub 2007 May 30.

PMID:
17534694
3.

Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.

Birnbaum Y, Atar S, Luo H, Nagai T, Siegel RJ.

Thromb Res. 1999 Dec 15;96(6):451-8.

PMID:
10632468
4.

High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: an in vitro and in vivo study.

Steffen W, Fishbein MC, Luo H, Lee DY, Nita H, Cumberland DC, Tabak SW, Carbonne M, Maurer G, Siegel RJ.

J Am Coll Cardiol. 1994 Nov 15;24(6):1571-9.

5.

Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.

Tratar G, Blinc A, Strukelj M, Mikac U, Sersa I.

Thromb Haemost. 2004 Mar;91(3):487-96.

PMID:
14983224
6.

Dissolution of peripheral arterial thrombi by ultrasound.

Ariani M, Fishbein MC, Chae JS, Sadeghi H, Michael AD, Dubin SB, Siegel RJ.

Circulation. 1991 Oct;84(4):1680-8.

PMID:
1914107
7.

A study to determine chest wall vibratory attachment interface locations for a low frequency sonic vibrator in treatment of acute coronary thrombosis.

Hoffmann AK, Gill H.

J Thromb Thrombolysis. 2011 Aug;32(2):167-76. doi: 10.1007/s11239-011-0589-2.

PMID:
21547406
8.
9.
12.

Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity.

Maheshwari N, Kantipudi S, Maheshwari A, Arora K, Vandana, Kwatra N, Sahni G.

PLoS One. 2016 Mar 14;11(3):e0150315. doi: 10.1371/journal.pone.0150315. eCollection 2016.

13.

Noninvasive thrombolysis using histotripsy beyond the intrinsic threshold (microtripsy).

Zhang X, Owens GE, Gurm HS, Ding Y, Cain CA, Xu Z.

IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Jul;62(7):1342-55. doi: 10.1109/TUFFC.2015.007016.

14.

Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.

Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM.

Nanomedicine (Lond). 2007 Aug;2(4):533-43.

PMID:
17716136
15.

The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound.

Adler Y, Attar D, Vaturi M, Golovchiner G, Iakobishvili Z, Battler A, Siegel RJ, Birnbaum Y.

Cardiovasc Drugs Ther. 2001 Mar;15(2):119-23.

PMID:
11669404
16.

Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.

Atar S, Neuman Y, Miyamoto T, Chen M, Birnbaum Y, Luo H, Kobal S, Siegel RJ.

J Thromb Thrombolysis. 2003 Jun;15(3):165-9.

PMID:
14739625
17.

Diastolic Timed Vibrator: Noninvasive Pre-Hospitalization Treatment of Acute Coronary Ischemia.

Marzencki M, Kajbafzadeh B, Khosrow-Khavar F, Tavakolian K, Kaminska B, Menon C.

IEEE Trans Biomed Circuits Syst. 2014 Jun;8(3):313-24. doi: 10.1109/TBCAS.2013.2270181. Epub 2013 Aug 7.

PMID:
23934670
18.

Cooling System Permits Effective Transcutaneous Ultrasound Clot Lysis In Vivo Without Skin Damage.

Luo H, Fishbein MC, Bar-Cohen Y, Nishioka T, Berglund H, Kim CJ, Nagai T, Birnbaum Y, Siegel RJ.

J Thromb Thrombolysis. 1998 Sep;6(2):125-131.

PMID:
10751794
19.

Effect of externally applied focused acoustic energy on clot disruption in vitro.

Westermark S, Wiksell H, Elmqvist H, Hultenby K, Berglund H.

Clin Sci (Lond). 1999 Jul;97(1):67-71.

PMID:
10369795
20.

Blood clot disruption in vitro using shockwaves delivered by an extracorporeal generator after pre-exposure to lytic agent.

Goldenstedt C, Birer A, Cathignol D, Lafon C.

Ultrasound Med Biol. 2009 Jun;35(6):985-90. doi: 10.1016/j.ultrasmedbio.2008.11.016. Epub 2009 Mar 13.

PMID:
19285784

Supplemental Content

Support Center